About Sanguina
Sanguina is a company based in Atlanta (United States) founded in 2014.. Sanguina has raised $2.8 million across 5 funding rounds from investors including HHS, Stephen Ippolito and George Hornig. Sanguina offers products and services including AnemoCheck Home, AnemoCheck Mobile, and Ruby Premium. Sanguina operates in a competitive market with competitors including Biomaneo, Blaze Medical Devices, DiaSpect, Aviv Biomedical and MicroDevice Engineering, among others.
- Headquarter Atlanta, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sanguina, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.8 M (USD)
in 5 rounds
-
Latest Funding Round
$2.8 M (USD), Series A
Jul 25, 2023
-
Investors
HHS
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sanguina
Sanguina offers a comprehensive portfolio of products and services, including AnemoCheck Home, AnemoCheck Mobile, and Ruby Premium. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kit for affordable anemia detection at home.
App for tracking and managing blood health.
Premium features for unlimited tests and personalized insights.
Unlock access to complete
Unlock access to complete
Funding Insights of Sanguina
Sanguina has successfully raised a total of $2.8M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.8 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $2.8M
-
First Round
First Round
(01 Jul 2015)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Series A - Sanguina | Valuation | Veritus Capital | |
| Sep, 2019 | Amount | Grant - Sanguina | Valuation |
investors |
|
| Sep, 2018 | Amount | Grant - Sanguina | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sanguina
Sanguina has secured backing from 5 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include HHS, Stephen Ippolito and George Hornig. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Veritus is engaged in socially responsible and sustainable investing.
|
Founded Year | Domain | Location | |
|
Early-stage entrepreneur-led investing is facilitated by The Seed Lab.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sanguina
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sanguina
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sanguina Comparisons
Competitors of Sanguina
Sanguina operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biomaneo, Blaze Medical Devices, DiaSpect, Aviv Biomedical and MicroDevice Engineering, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neonatal screening kits for sickle cell disease are developed.
|
|
| domain | founded_year | HQ Location |
Testing of blood damage and health of RBC
|
|
| domain | founded_year | HQ Location |
Handheld hemoglobin analyzers for reagent-free whole blood testing are developed.
|
|
| domain | founded_year | HQ Location |
Aviv Biomedical offers a portfolio of spectrometers and fluorometers.
|
|
| domain | founded_year | HQ Location |
Develops point-of-care devices for effective anemia screening in healthcare settings.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sanguina
Frequently Asked Questions about Sanguina
When was Sanguina founded?
Sanguina was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Sanguina located?
Sanguina is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Is Sanguina a funded company?
Sanguina is a funded company, having raised a total of $2.8M across 5 funding rounds to date. The company's 1st funding round was a Grant of $247.17K, raised on Jul 01, 2015.
What does Sanguina do?
Founded in 2014 and based in Atlanta, United States, operations are focused on health diagnostics. A disposable point-of-care testing device is developed and marketed for anemia detection. Analysis of one blood droplet is performed via a chemical reagent that generates color changes indicating hemoglobin levels. Results are obtained in approximately 60 seconds without electrical power requirements. Integration with smartphones is supported for automated correlation to specific hemoglobin measurements.
Who are the top competitors of Sanguina?
Sanguina's top competitors include Biomaneo, DiaSpect and Blaze Medical Devices.
What products or services does Sanguina offer?
Sanguina offers AnemoCheck Home, AnemoCheck Mobile, and Ruby Premium.
Who are Sanguina's investors?
Sanguina has 5 investors. Key investors include HHS, Stephen Ippolito, George Hornig, Veritus, and The Seed Lab.